Archives: Agenda

• Understanding where compliance and operational risks most commonly arise in pharma air freight supply chains,
• Managing regulatory challenges, including Good Distribution Practice (GDP), and the role of CEIV Pharma in mitigating risks and ensuring compliance.
• Applying practical risk mitigation tools and planning strategies during transportation to avoid disruption and temperature excursions

• Understanding how recent disruptions including natural events and geopolitical challenges have impacted supply chains
• Learning how sponsors adapted routes suppliers and timelines to keep trials running
• Identifying practical strategies to build flexibility visibility and faster decision making into supply operations

1 x Biopharma panel seat available

1 x Vendor panel seat available

• Identifying practical use cases
• Understanding where AI improves efficiency
• Avoiding overinvestment

• What changes for sponsors when EHDS, eIDAS 2.0 wallets, the Data Governance Act and the AI Act converge on clinical trial data infrastructure.
• Why current consent and audit-trail architectures will not survive a participant’s right to revoke or port their data, and what the Nordic region is already building as the working answer: consent evidence ledgers, privacy-preserving computation, and neutral data altruism intermediaries

• Sharing practical examples of what has worked (and what hasn’t)
• Highlighting key challenges and how to overcome them
• Comparing tools in terms of ease of implementation, cost, and impact for smaller teams
• Exploring which solutions are realistically adoptable within limited resources and existing systems